Evernest Financial Advisors LLC bought a new position in shares of Oracle Corporation (NYSE:ORCL – Free Report) in the 2nd quarter, HoldingsChannel reports. The fund bought 1,141 shares of the enterprise software provider’s stock, valued at approximately $250,000.
Several other hedge funds and other institutional investors also recently made changes to their positions in ORCL. Nuveen LLC bought a new stake in shares of Oracle during the first quarter worth about $732,692,000. Vanguard Group Inc. increased its position in shares of Oracle by 2.2% during the first quarter. Vanguard Group Inc. now owns 160,925,413 shares of the enterprise software provider’s stock worth $22,498,982,000 after acquiring an additional 3,513,464 shares in the last quarter. Kingstone Capital Partners Texas LLC bought a new stake in shares of Oracle during the second quarter worth about $731,512,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of Oracle by 79.2% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,638,951 shares of the enterprise software provider’s stock worth $648,572,000 after acquiring an additional 2,049,687 shares in the last quarter. Finally, Assenagon Asset Management S.A. increased its position in shares of Oracle by 840.7% during the second quarter. Assenagon Asset Management S.A. now owns 2,119,473 shares of the enterprise software provider’s stock worth $463,380,000 after acquiring an additional 1,894,157 shares in the last quarter. 42.44% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several equities research analysts have recently commented on ORCL shares. Stifel Nicolaus boosted their target price on shares of Oracle from $250.00 to $350.00 and gave the stock a “buy” rating in a research report on Wednesday, September 10th. Wolfe Research boosted their price target on shares of Oracle from $300.00 to $400.00 and gave the stock an “outperform” rating in a report on Wednesday, September 10th. Guggenheim boosted their price target on shares of Oracle from $250.00 to $375.00 and gave the stock a “buy” rating in a report on Wednesday, September 10th. Baird R W upgraded shares of Oracle to a “strong-buy” rating in a report on Wednesday, October 8th. Finally, The Goldman Sachs Group boosted their price target on shares of Oracle from $195.00 to $310.00 and gave the stock a “neutral” rating in a report on Monday, September 15th. Three equities research analysts have rated the stock with a Strong Buy rating, twenty-seven have given a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $307.00.
Oracle Stock Up 1.4%
ORCL opened at $303.30 on Thursday. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 3.33. The stock has a market cap of $864.64 billion, a price-to-earnings ratio of 70.21, a PEG ratio of 3.22 and a beta of 1.53. Oracle Corporation has a twelve month low of $118.86 and a twelve month high of $345.72. The company’s 50-day moving average price is $269.61 and its two-hundred day moving average price is $213.14.
Oracle (NYSE:ORCL – Get Free Report) last released its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing analysts’ consensus estimates of $1.48 by ($0.01). The company had revenue of $14.93 billion during the quarter, compared to analysts’ expectations of $15.04 billion. Oracle had a net margin of 21.08% and a return on equity of 72.93%. The firm’s revenue was up 12.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.39 earnings per share. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. As a group, equities analysts expect that Oracle Corporation will post 5 earnings per share for the current year.
Oracle Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, October 23rd. Shareholders of record on Thursday, October 9th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Thursday, October 9th. Oracle’s payout ratio is presently 46.30%.
Insider Transactions at Oracle
In related news, Director Naomi O. Seligman sold 2,222 shares of the company’s stock in a transaction that occurred on Friday, September 26th. The shares were sold at an average price of $288.91, for a total transaction of $641,958.02. Following the sale, the director directly owned 29,225 shares in the company, valued at approximately $8,443,394.75. This represents a 7.07% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Clayton M. Magouyrk sold 21,241 shares of the company’s stock in a transaction that occurred on Friday, September 12th. The shares were sold at an average price of $297.11, for a total transaction of $6,310,913.51. Following the sale, the insider owned 78,000 shares in the company, valued at $23,174,580. The trade was a 21.40% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 120,769 shares of company stock valued at $36,428,967. Corporate insiders own 40.90% of the company’s stock.
Oracle Company Profile
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Featured Articles
- Five stocks we like better than Oracle
- What Are Dividend Challengers?
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- How to Use Stock Screeners to Find Stocks
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- Quiet Period Expirations Explained
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.